Form 4: Exact Sciences CEO Kevin Conroy Reports Stock Transactions
SEC Form 4 Filing
CEO Kevin Conroy reports acquisition and disposal of Exact Sciences (EXAS) stock and restricted stock units.
Summary
- On February 26, 2024, Kevin Conroy, CEO of Exact Sciences, acquired 13,181 shares of common stock upon vesting of restricted stock units.
- On February 27, 2024, Conroy sold 6,263 shares at $56.89 per share to cover withholding taxes related to the vesting of restricted stock units.
- Following these transactions, Conroy directly owns 1,289,624 shares of common stock.
- Conroy also indirectly owns 27,924 shares held in a 401(k) plan and 65,189 shares held in Grantor Retained Annuity Trusts.
- Conroy also holds 701,161 vested and unvested options to purchase shares of common stock and restricted stock units.
- Conroy acquired 88,671 restricted stock units that vest in four equal annual installments beginning on February 28, 2025.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document primarily reports stock transactions, with no explicit positive or negative implications. The sale of shares is explained as covering tax obligations.
Positives
- The vesting of restricted stock units and subsequent acquisition of shares by the CEO could be seen as a positive sign of alignment with company performance.
Negatives
- The sale of shares by the CEO, even if for tax purposes, could be interpreted negatively by some investors.
Risks
- Executive stock transactions are always subject to scrutiny and can influence investor sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Sell-to-cover transactions are a standard practice when restricted stock units vest, allowing executives to meet their tax obligations without having to use personal funds.
Stakeholder Impact
- The transactions could have a minor impact on shareholders depending on how they interpret the CEO's actions.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Restricted stock units vested, resulting in the acquisition of 13,181 shares. |
| 02/27/2024 | 6,263 shares were sold at $56.89 to cover withholding taxes. |
| 02/28/2025 | Vesting start date for 88,671 restricted stock units in four equal annual installments. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.